Dovetail uses proximity ligation technology in genomics, providing insights into genomic structures and variations.
Dovetail Genomics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in November 2024.
Dovetail Genomics's investors include National Human Genome Research Institute.
Dovetail Genomics is headquartered in Scotts Valley, United States.
Dovetail uses proximity ligation technology in genomics, providing insights into genomic structures and variations.
Dovetail Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dovetail Genomics — Funding & Investors." VCBacked, November 6, 2024, https://www.vcbacked.co/company/dovetail-genomics. Accessed August 16, 2026.
VCBacked. (2024). Dovetail Genomics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/dovetail-genomics
{{cite web |title=Dovetail Genomics — Funding & Investors |url=https://www.vcbacked.co/company/dovetail-genomics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated